{
    "eid": "2-s2.0-84908126534",
    "title": "Adaptation of international guidelines for metastatic colorectal cancer: An Asian consensus",
    "cover-date": "2014-09-01",
    "subject-areas": [
        {
            "$": "Gastroenterology",
            "@code": "2715"
        },
        {
            "$": "Oncology",
            "@code": "2730"
        }
    ],
    "keywords": [
        "Asia",
        "Chemotherapy",
        "Epidermal growth factor receptor (EGFR)-specific monoclonal antibody",
        "KRAS",
        "Targeted therapy"
    ],
    "authors": [
        "Ann Lii Cheng"
    ],
    "citedby-count": 16,
    "ref-count": 28,
    "ref-list": [
        "Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008",
        "GLOBOCAN 2008 v2.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 10",
        "The oncosurgery approach to managing liver metastases from colorectal cancer: A multidisciplinary international consensus",
        "Management of colon cancer: Resource-stratified guidelines from the Asian Oncology Summit 2012",
        "Increasing incidence of colorectal cancer in Asia: Implications for screening",
        "J Clin Oncol",
        "NCCN Clinical Practice Guidelines in Oncology. Colon Cancer, Version 3.2013",
        "NCCN Clinical Practice Guidelines in Oncology. Rectal Cancer, Version 4.2013",
        "Esmo consensus guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making",
        "Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer-an expert review from the international congress on anti-cancer treatment (ICACT) 2009",
        "FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: A randomized GERCOR study",
        "Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial",
        "Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: The choice and schedule of fluoropyrimidine matters",
        "Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: The gruppo oncologico nord ovest",
        "Long-term outcome of initially unresectable metastatic colorectal cancer patients treated with 5-fluorouracil/leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) followed by radical surgery of metastases",
        "Efficacy of capecitabine versus 5-fluorouracil in colorectal and gastric cancers: A meta-analysis of individual data from 6171 patients",
        "Phase II study of S-1 combined with irinotecan (CPT-11) in patients with advanced colorectal cancer",
        "A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer",
        "Phase II study of combined treatment with irinotecan and S-1 (IRIS) in patients with inoperable or recurrent advanced colorectal cancer (HGCSG0302)",
        "Randomized controlled trial of cetuximab plus chemotherapy for patients with KRAS wild-type unresectable colorectal liver-limited metastases",
        "Cetuximab plus irinotecan, fluorouracil, and leucovorin as first-line treatment for metastatic colorectal cancer: Updated analysis of overall survival according to tumor KRAS and BRAF mutation status",
        "Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: A randomised phase 2/3 non-inferiority study (FIRIS study)",
        "S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for first-line treatment of patients with metastatic colorectal cancer: A randomised, non-inferiority phase 3 trial",
        "Efficacy according to biomarker status of cetuximab plus FOLFOX-4 as first-line treatment for metastatic colorectal cancer: The OPUS study",
        "Fluorouracil, leucovorin, and oxaliplatin with and without cetuximab in the first-line treatment of metastatic colorectal cancer",
        "Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer",
        "Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group Trial 01.04",
        "PET and PET-CT for evaluation of colorectal carcinoma"
    ],
    "affiliation": [
        {
            "affiliation-city": "Kaohsiung",
            "affilname": "Kaohsiung Medical University Chung-Ho Memorial Hospital",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Shanghai",
            "affilname": "Fudan University Shanghai Cancer Center",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Gurugram",
            "affilname": "Medanta - The Medicity",
            "affiliation-country": "India"
        },
        {
            "affiliation-city": "Shanghai",
            "affilname": "Shanghai Jiao Tong University School of Medicine",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Oldenburg",
            "affilname": "Klinikum Oldenburg",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Taipei",
            "affilname": "National Taiwan University Hospital",
            "affiliation-country": "Taiwan"
        },
        {
            "affiliation-city": "Makati",
            "affilname": "Makati Medical Center",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Quezon City",
            "affilname": "St. Luke's Medical Center Quezon City",
            "affiliation-country": "Philippines"
        },
        {
            "affiliation-city": "Depok",
            "affilname": "Universitas Indonesia",
            "affiliation-country": "Indonesia"
        },
        {
            "affiliation-city": "Kuala Lumpur",
            "affilname": "Universiti Malaya",
            "affiliation-country": "Malaysia"
        },
        {
            "affiliation-city": "Naples",
            "affilname": "Universit\u00e0 degli Studi della Campania Luigi Vanvitelli",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "Prince of Wales Hospital Hong Kong",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Samsung Medical Center, Sungkyunkwan university",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "Yonsei University College of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Shanghai",
            "affilname": "Fudan University",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Hong Kong",
            "affilname": "The University of Hong Kong",
            "affiliation-country": "Hong Kong"
        },
        {
            "affiliation-city": "Seoul",
            "affilname": "University of Ulsan College of Medicine",
            "affiliation-country": "South Korea"
        },
        {
            "affiliation-city": "Hangzhou",
            "affilname": "Zhejiang University",
            "affiliation-country": "China"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Baltimore",
            "affilname": "Johns Hopkins University School of Medicine",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Chiang Mai",
            "affilname": "Chiang Mai University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Belo Horizonte",
            "affilname": "HCor Onco",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": null,
            "affilname": "MScript Ltd",
            "affiliation-country": "United Kingdom"
        },
        {
            "affiliation-city": "Singapore City",
            "affilname": "H.L. Kong Medical Oncology Centre Pte Ltd",
            "affiliation-country": "Singapore"
        }
    ],
    "funding": [
        "EMD Serono"
    ]
}